For patients on continuous medication for pain relief in late-stage illness, the FDA has approved methylnaltrexone bromide (Relistor) injection for treatment of opioid-induced constipation.
References and Resources
FDA Approves Relistor for Opioid-Induced Constipation
Sponsored by The Doctor’s Channel